EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial
Clinical trial NCT07187284 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07187284
- Sponsor
- Zhongda Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2026-09-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.